Autres langues Zynex, Inc.

Actions

Temps réel estimé Cboe BZX Autres places de cotation 19:22:28 29/04/2024			Varia. 5j.	Varia. 1 janv.
11,43 ^USD	+1,96%		+2,96%	+5,33%

01/03	ZYNEX, INC. : RBC Capital Markets maintient sa recommandation à l'achat	ZM
29/02	Zynex, Inc. communique ses prévisions de résultats pour le premier trimestre et l'année 2024	CI

Zynex Sets First Quarter 2024 Earnings Call	18/04
Zynex Earns Prestigious 2024 Top Workplaces USA Employer Recognition Award	02/04
Zynex Reports Fourth Quarter and Full Year 2023 Financial Results	01/03
Zynex, Inc. Provides Earnings Guidance First Quarter and Full Year 2024	29/02
Tranche Update on Zynex, Inc.'s Equity Buyback Plan announced on September 11, 2023.	29/02
Tranche Update on Zynex, Inc.'s Equity Buyback Plan announced on November 1, 2023.	29/02
Zynex, Inc. announces an Equity Buyback for $20 million worth of its shares.	29/02
Earnings Flash (ZYXI) ZYNEX Reports Q4 Revenue $47.3M, vs. Street Est of $55.6M	29/02
Zynex, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	29/02
Zynex, Inc. authorizes a Buyback Plan.	29/02
Zynex Sets Fourth Quarter and Full Year 2023 Earnings Call	22/02
Zynex Introduces New Products	20/02
Zynex, Inc. Introduces New Products	20/02
Zynex Receives FDA Clearance for its Next Generation NMES Device	07/02
Zynex Receives US FDA Approval for Muscle Stimulation Device	06/02
Zynex, Inc. Receives FDA Clearance for its Next Generation NMES Device	06/02
Zynex Recognized in Top 25 Medical Device Companies for 2024	02/02
Zynex to Participate at the Needham Annual Growth Conference	08/01
Zynex, Inc.'s Equity Buyback announced on September 11, 2023, has closed with 1,161,536 shares, representing 3.3% for $10 million.	31/12
Zynex Ranked in Forbes List of 'America's Most Successful Small-Cap Companies 2024'	16/11

Aucun résultat pour cette recherche